Skip to main content

Table 2 Characteristics of patients with and without cardiovascular drugs, Swedish Dementia Registry 2007 to 2012

From: Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry

  CV medication (n= 13,847) Without CV medication (n= 5,896) P value
Age    
Mean 79.6 ± 7.2 77.4 ± 8.9 <0.001
Range 33 to 103 27 to 97
Gender    
Female (%) 55.9 64.4 <0.001
Male (%) 44.1 35.6
MMSE    
Mean 21.4 ± 4.9 21.3 ± 5.2 <0.001
Range 0 to 30 0 to 30
Living alone (%) 43.7 45.7 0.006
ChEIs (%) 46.1 58.5 <0.001
NMDA antagonists (%) 10.6 10.3 0.028
Number of drugs    
Mean 5.8 ± 3 3,0 ± 2.5 <0.001
Range 0 to 24 0 to 21
AD (%) 34.9 56.0 <0.001
MixD (%) 28.9 20.4 <0.001
VaD (%) 30.3 13.2 <0.001
DLB (%) 2.6 4.2 <0.001
FTD (%) 1.6 3.2 <0.001
PDD (%) 1.7 2.9 <0.001
  1. AD, Alzheimer’s disease; ChEI, cholinesterase inhibitor; CV, cardiovascular; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; MixD, mixed dementia; MMSE, Mini Mental State Examination; NMDA, N-methyl-d-aspartate; PDD, Parkinson’s disease dementia; VaD, vascular dementia.